Dr. Benjamin Starnes (Seattle, WA, USA) demonstrates all important features of a well-organized and 'busy' aortic center and analyzes the added value of centralization of the aortic treatment. Moreover, Dr. Starnes summarizes all lessons learned during the establishment of the aortic center, which may help physicians to further optimize the EVAR outcomes in the treatment of ruptured AAAs.
Dr. Andrea Kahlberg (Milan, Italy) provides a comprehensive overview of their paper about the treatment strategies and outcomes of openr repair in case fo infected graft and endograft infections in the descending aorta.
Prof. Alberto Cossini (Milan, Italy) provides an overview of the current guidelines about the LDL levels, explains the mechanism of action of the PCSK9 inhibitors and discusses novel therapies for lipids disorders.
Clinical Summary
- 28 year old male
- Traumatic aortic injury (TAI)
- Endovascular treatment
Complications
- Aortic arch and brachiocephalic trunk dissection
- Right carotid artery and left sublcavian artery occlusion
- Stroke
- Orthostatic Hypotension (Extracranial Steal Syndromes from Disease of the Aortic Branches?)
Surgery Technique
- Femoro-femoral and right axillary artery cannulation
- The aorta was accessed through a Ministernotomy
How does calcium influence your treatment strategy? A short presentation regarding the impact of calcium in the treatment of femoropopliteal disease and a proposed algorithm for the use of scaffolds or 'leave-nothing-behind' strategies for severely calcified lesions.
Patient’s characteristics
Gender: Female
Age: 65 years old
Comorbidity: Arterial hypertension, Dyslipidemia
Symptoms: Acute onset of claudication (<2 weeks), Rutherford class 3 of the left limb
Previous operations: None
ABI: 0.5
DUS: Occlusion of the left popliteal artery
This presentations gives a critical overview of the Drug-coated balloons in the BTK-area. Where do we stand and what are the open questions. Review of all available studies and the literature.
6-month results of the Legflow DCB in real-world TASC C&D femoropopliteal lesions, first presented at LINC 2019.
Investigating the iVolution 3rd generation nitinol stent in TASC A&B femoropopliteal lesions : 24-month outcomes in the EVOLUTION study, first presented at LINC 2019.
ZILVER PTX treatment versus bypass surgery for the treatment of TASC C&D fempop lesions.
Final 12-month results of the ZILVERPASS study, first presented at LINC 2019.
